- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for the treatment of tuberculosis
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 16, Issue 1, Pages 1-21
Publisher
Informa Healthcare
Online
2010-09-26
DOI
10.1517/14728214.2011.521497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
- (2010) V. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis
- (2010) W. Shi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
- (2010) Keertan Dheda et al. LANCET
- Treatment of latent tuberculosis infection: An update
- (2010) Philip LOBUE et al. RESPIROLOGY
- Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
- (2009) Susan E. Dorman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Update on Rifampin and Rifabutin Drug Interactions
- (2009) Anne M. Baciewicz et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence of Fluoroquinolone Resistance among Tuberculosis Patients in Shanghai, China
- (2009) P. Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem-Clavulanate: A New Strategy for the Treatment of Tuberculosis?
- (2009) Ulrike Holzgrabe ChemMedChem
- Biomarkers of Disease Activity, Cure, and Relapse in Tuberculosis
- (2009) T. Mark Doherty et al. CLINICS IN CHEST MEDICINE
- A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
- (2009) G. B. Migliori et al. EUROPEAN RESPIRATORY JOURNAL
- Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
- (2009) W. W. Yew et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
- (2009) W.-J. Koh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
- (2009) Marcus B Conde et al. LANCET
- Inhibitors selective for mycobacterial versus human proteasomes
- (2009) Gang Lin et al. NATURE
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
- (2009) J.-E. Hugonnet et al. SCIENCE
- Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis
- (2008) Reynaldo Dietze et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis
- (2008) Nicolas Veziris et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model
- (2008) N. Lounis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selective Killing of Nonreplicating Mycobacteria
- (2008) Ruslana Bryk et al. Cell Host & Microbe
- Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
- (2008) L. Amaral et al. CURRENT DRUG TARGETS
- Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in humanMycobacterium tuberculosisinfection
- (2008) Ankita Garg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Management of multidrug-resistant tuberculosis in the Asia-Pacific region
- (2008) Wing-Wai YEW RESPIROLOGY
- Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug
- (2004) Lee Jia et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation